drugset / Trial / NCT01744574
Sex Differences, Hormones & Smoking Cessation
RandomizedParallel-groupDouble-blindPrevention
Summary
Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on impulsivity and smoking cessation in a sample of males and females who are motivated to quit smoking.
Timeline
- Start
- 2012-12
- Primary completion
- 2017-07-27
- Completion
- 2017-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 200 mg | Oral |